Pluristem Therapeutics Announces Completion of 2nd Cohort and DSMB Approval to Enroll Final Cohort in Phase I Hematological Study of PLX-R18

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling

Paul Theisen
Patient Acquisition

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

Stacey Gandler
Brand Nourishment

Amy Giles
Increasing Engagement

Pat Purcell
Meeting Engagement

Matt Turner
Patient Affordability

Suma Ramadas, PhD
Medical Affairs

Brenda Snow
Authentic Patient Voice

David Linetsky
Point-of-Care Marketing